Precision for Medicine

Pharmaceutical and healthcare company Precision for Medicine has acquired Applied Immunology, a custom cell-based and immunoassay solutions provider.

Precision for Medicine expects that the move will help to expand its targeted therapeutics across immunology, rare diseases and biosimilars. It will also assist in developing its laboratory services in cell-based and immunoassays.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Veristat has acquired Spero Oncology, a clinical operations provider for oncology trials, with plans to expand its services in Europe.

Following the take over, Veristat will be able to provide full clinical operations support, including feasibility studies, legal representations, clinical monitoring and project management services in Europe.


Image: Precision for Medicine has acquired Applied Immunology. Photo: Courtesy of Precision for Medicine.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact